Webinar Registration

Loading…

Karin Gleason
Meteorologist, Climate Monitoring
NOAA’s National Centers for Environmental Information (NCEI)

www.aauwnc.org/weather-climate-and-you-11-19-2020/

Karin has been with NCEI, formerly the National Climatic Data Center (NCDC), for the past 20 years. Early in her career, she focused on quality control of historical weather data, expanding the digital climate archive with the Climate Data Modernization Program (CDMP). She has been a member of Climate Monitoring for the last 19 years, developing applications to make climate data accessible online, contributing to global climate reports, summarizing and communicating the climate of the U.S., adjudicating state climate extremes records, and connecting with stakeholders to create meaningful products for a wide array of customers. Karin is an advocate for use-inspired product development.
Karin received a BS in Meteorology from Valparaiso University and a MS in Meteorology from Texas A&M University. She has two teenage children and has been married to her husband for 25 years.

Climate Monitoring at NOAA's National Centers for Environmental Information is committed to the monitoring and assessment of the state of the Earth's climate in near real-time, providing decision-makers at all levels of the public and private sectors with data and information on climate trends and variability. Karin is a key scientist, providing data research and analysis and is the developer of the Climate Extremes Index (CEI), often used to quantify recent extremes in observed temperatures, precipitation, and drought across the contiguous US. She also is the lead author for the monthly report on US climate information published as the NOAA Climate Science & Services Monthly Climate Update. Locally, Karin teaches a 4-week course at the NC Arboretum and enjoys adult education and media interactions. ...

Photo

View on Facebook

·Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

AAUW of North Carolina updated their cover photo.

2 weeks ago

Register Here: www.aauwnc.org/weather-climate-and-you-11-19-2020/ ...

Photo

View on Facebook

·Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

AAUW of North Carolina updated their cover photo.

2 weeks ago

AAUW of North Carolina's cover photo ...

Photo

View on Facebook

·Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

AAUW of North Carolina

4 weeks ago

Someone we should all know about...On her very first, simple assignment at the FDA, Frances Kathleen Oldham Kelsey did something very unexpected. She refused to approve a sleeping pill that was already widely used in the UK and Europe.

This wasn’t her first job. By 1960, she had already earned her PhD in pharmacology and her MD from the University of Chicago. She had taught pharmacology at the University of South Dakota as well as being a family doctor. But it was a move to DC with her husband and two young daughters that had her working at the Food and Drug Administration. And she just couldn’t reconcile the data with the purported safety of the sleeping pill that was now also being touted as a morning sickness wonder. She asked the William S. Merrell pharmaceutical company for more information. They responded. She asked for more. They complained to her boss, saying she was a ‘fussy, stubborn, unreasonable bureaucrat’. ‘But, still, she persisted’ and she refused to hurry her approval.

By the next year, reports had started to come in from Europe that the drug had been linked to birth defects. Merrell started to deny that their product had any part in the wave of birth defects, then withdrew their application when the data showed their culpability. Kevadon, more commonly known as thalidomide, was never made legal in the United States because of Kelsey. Merrell had sent out samples to physicians prior to approval, and 17 babies were born in the US with the deformities, while in Europe alone it is estimated there were tens of thousands. The outcry against Kelsey ceased.

The year after the banning of thalidomide in the US, Kelsey was put in charge of the new FDA branch to test and regulate new drugs. She would work with the FDA for 45 years rewriting the medical-testing regulations, strengthening people’s protections and against medical conflicts of interest. She required informed consent be obtained in clinical trials, adverse reactions be reported to the FDA, and that drugs needed to be both safe and effective. The rules she helped shape have been adopted worldwide.

Born in 1914, she lived to be 101 years old. Before her death in 2015, she was inducted into the National Women's Hall of Fame, had a school named after her, and received the President's Award for Distinguished Federal Civilian Service.
She had become a naturalized American in 1956, and was appointed to the Order of Canada a day before her death. ...

Webinar Registration

Share this: